These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 15078152)

  • 21. Biomimetic control of vascular smooth muscle cell morphology and phenotype for functional tissue-engineered small-diameter blood vessels.
    Chan-Park MB; Shen JY; Cao Y; Xiong Y; Liu Y; Rayatpisheh S; Kang GC; Greisler HP
    J Biomed Mater Res A; 2009 Mar; 88(4):1104-21. PubMed ID: 19097157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phenotypical plasticity of vascular smooth muscle cells-effect of in vitro and in vivo shear stress for tissue engineering of blood vessels.
    Opitz F; Schenke-Layland K; Cohnert TU; Stock UA
    Tissue Eng; 2007 Oct; 13(10):2505-14. PubMed ID: 17685849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vascular smooth muscle cells as a valvular interstitial cell surrogate in heart valve tissue engineering.
    Appleton AJ; Appleton CT; Boughner DR; Rogers KA
    Tissue Eng Part A; 2009 Dec; 15(12):3889-97. PubMed ID: 19563261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Construction of cell-containing, anisotropic, three-dimensional collagen fibril scaffolds using external vibration and their influence on smooth muscle cell phenotype modulation.
    Zeng YN; Kang YL; Rau LR; Hsu FY; Tsai SW
    Biomed Mater; 2017 Aug; 12(4):045019. PubMed ID: 28569670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vascular extracellular matrix and fibroblasts-coculture directed differentiation of human mesenchymal stem cells toward smooth muscle-like cells for vascular tissue engineering.
    Li N; Sanyour H; Remund T; Kelly P; Hong Z
    Mater Sci Eng C Mater Biol Appl; 2018 Dec; 93():61-69. PubMed ID: 30274093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toward improved myocardial maturity in an organ-on-chip platform with immature cardiac myocytes.
    Sheehy SP; Grosberg A; Qin P; Behm DJ; Ferrier JP; Eagleson MA; Nesmith AP; Krull D; Falls JG; Campbell PH; McCain ML; Willette RN; Hu E; Parker KK
    Exp Biol Med (Maywood); 2017 Nov; 242(17):1643-1656. PubMed ID: 28343439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. I-Wire Heart-on-a-Chip II: Biomechanical analysis of contractile, three-dimensional cardiomyocyte tissue constructs.
    Schroer AK; Shotwell MS; Sidorov VY; Wikswo JP; Merryman WD
    Acta Biomater; 2017 Jan; 48():79-87. PubMed ID: 27818306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Smooth muscle-like tissue constructs with circumferentially oriented cells formed by the cell fiber technology.
    Hsiao AY; Okitsu T; Onoe H; Kiyosawa M; Teramae H; Iwanaga S; Kazama T; Matsumoto T; Takeuchi S
    PLoS One; 2015; 10(3):e0119010. PubMed ID: 25734774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Self-Folded Hydrogel Tubes for Implantable Muscular Tissue Scaffolds.
    Vannozzi L; Yasa IC; Ceylan H; Menciassi A; Ricotti L; Sitti M
    Macromol Biosci; 2018 Apr; 18(4):e1700377. PubMed ID: 29537714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insoluble elastin reduces collagen scaffold stiffness, improves viscoelastic properties, and induces a contractile phenotype in smooth muscle cells.
    Ryan AJ; O'Brien FJ
    Biomaterials; 2015 Dec; 73():296-307. PubMed ID: 26431909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unraveling the role of mechanical stimulation on smooth muscle cells: A comparative study between 2D and 3D models.
    Bono N; Pezzoli D; Levesque L; Loy C; Candiani G; Fiore GB; Mantovani D
    Biotechnol Bioeng; 2016 Oct; 113(10):2254-63. PubMed ID: 26987444
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Automated Contraction Analysis of Human Engineered Heart Tissue for Cardiac Drug Safety Screening.
    Mannhardt I; Saleem U; Benzin A; Schulze T; Klampe B; Eschenhagen T; Hansen A
    J Vis Exp; 2017 Apr; (122):. PubMed ID: 28448053
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Engineered heart tissues and induced pluripotent stem cells: Macro- and microstructures for disease modeling, drug screening, and translational studies.
    Tzatzalos E; Abilez OJ; Shukla P; Wu JC
    Adv Drug Deliv Rev; 2016 Jan; 96():234-244. PubMed ID: 26428619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. I-Wire Heart-on-a-Chip I: Three-dimensional cardiac tissue constructs for physiology and pharmacology.
    Sidorov VY; Samson PC; Sidorova TN; Davidson JM; Lim CC; Wikswo JP
    Acta Biomater; 2017 Jan; 48():68-78. PubMed ID: 27818308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the use of in vitro methodologies as tools for screening new compounds for potential in vivo toxicity.
    Luber-Narod J; Smith B; Grant W; Jimeno JM; López-Lázaro L; Faircloth GT
    Toxicol In Vitro; 2001; 15(4-5):571-7. PubMed ID: 11566593
    [No Abstract]   [Full Text] [Related]  

  • 36. Cell mechanics studied by a reconstituted model tissue.
    Wakatsuki T; Kolodney MS; Zahalak GI; Elson EL
    Biophys J; 2000 Nov; 79(5):2353-68. PubMed ID: 11053115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An airway smooth muscle cell niche under physiological pulsatile flow culture using a tubular dense collagen construct.
    Ghezzi CE; Risse PA; Marelli B; Muja N; Barralet JE; Martin JG; Nazhat SN
    Biomaterials; 2013 Mar; 34(8):1954-66. PubMed ID: 23257180
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High content screening for modulators of cardiac differentiation in human pluripotent stem cells.
    Spiering S; Davidovics H; Bushway PJ; Mercola M; Willems E
    Methods Mol Biol; 2015; 1263():43-61. PubMed ID: 25618335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Force characteristics of in vivo tissue-engineered myocardial constructs using varying cell seeding densities.
    Birla R; Dhawan V; Huang YC; Lytle I; Tiranathanagul K; Brown D
    Artif Organs; 2008 Sep; 32(9):684-91. PubMed ID: 18684210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of Transcription Factor GAX and Concomitant Downregulation of IL-1β and ERK1/2 Modulate Vascular Smooth Muscle Cell Phenotype in 3D Fibrous Scaffolds.
    Lin S; Mequanint K
    Tissue Eng Part A; 2015 Sep; 21(17-18):2356-65. PubMed ID: 26041434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.